← Back to Search

Intervention for Diabetic Retinopathy

N/A

Waitlist Available

Research Sponsored by University of Illinois at Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients with type 2 diabetes

Patients with a history of at least moderate non-proliferative diabetic retinopathy

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and 6-week

Awards & highlights

Study Summary

This trial is testing a 6-week intervention called Amplify-RHYTHM to see how it affects patients with diabetic retinopathy. They will measure things like sleep quality, hormone levels, and

Who is the study for?

This trial is for individuals with diabetic retinopathy, a condition affecting the eyes due to diabetes. Participants should be interested in trying a new intervention called Amplify-RHYTHM for 6 weeks to potentially improve their sleep and biological rhythms.Check my eligibility

What is being tested?

The study is testing Amplify-RHYTHM, an intervention designed to optimize circadian rhythms over a period of 6 weeks. It aims to assess changes in sleep quality, stress hormones like cortisol and melatonin, as well as blood sugar levels using continuous monitoring.See study design

What are the potential side effects?

Potential side effects are not specified but may include discomfort or changes in sleep patterns due to the adjustment of daily routines or dietary habits as part of the circadian optimization process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have type 2 diabetes.

Select...

I have had moderate diabetic eye disease in the past.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and 6-week

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and 6-week

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 6-week for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Sleep

Secondary outcome measures

Glucose levels

Salivary melatonin and cortisol

Trial Design

1Treatment groups

Experimental Treatment

Group I: InterventionExperimental Treatment1 Intervention

Amplify-RHYTHM will consist of two main components: 1) timed light exposure, 2) weekly remote coaching session.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor

610 Previous Clinical Trials

1,559,429 Total Patients Enrolled

1 Trials studying Diabetic Retinopathy

36 Patients Enrolled for Diabetic Retinopathy

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which individuals meet the eligibility criteria to be enrolled in this research study?

"To be eligible for participation in this clinical trial, individuals must have a diagnosis of diabetic retinopathy and fall between the ages of 40 and 65. The trial aims to enroll approximately 30 participants."

Answered by AI

Are there any vacancies available for patients to participate in this trial?

"Apologies for the misunderstanding. According to clinicaltrials.gov, this specific trial is not currently seeking participants as it was posted on February 1st, 2024 and last updated on December 13th, 2023. However, there are still a total of 111 ongoing studies that are actively enrolling patients at this time."

Answered by AI

Is the clinical trial open to individuals in the age bracket of 85 and above?

"To be considered eligible for this clinical trial, individuals must fall within the age range of 40 to 65 years old. It is noteworthy that there are a total of 25 ongoing trials specifically targeting patients below the age of 18 and an additional 96 trials focusing on individuals aged over 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Circadian Amplification in Diabetic Retinopathy

2024. "Circadian Amplification in Diabetic Retinopathy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06183476.

All > Diabetic Retinopathy